Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.
about
Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis Major Outer Membrane ProteinA vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challengeIncreased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infectionInduction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexesImmunity to murine chlamydial genital infection.Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challengeVaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria.Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate modelChlamydia trachomatis vaccine research through the years.Cellular immunity and Chlamydia genital infection: induction, recruitment, and effector mechanisms.Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.ISCOM-based vaccines: the second decade.Recent trends in vaccine delivery systems: A review.Delivery of Chlamydia vaccines.Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatisChlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.Update on Chlamydia trachomatis Vaccinology.Vaccination to protect against infection of the female reproductive tract.Co-administration of the polysaccharide of Lycium barbarum with DNA vaccine of Chlamydophila abortus augments protection.Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.Mucosal and systemic immune responses to plasmid protein pgp3 in patients with genital and ocular Chlamydia trachomatis infection.
P2860
Q24793733-3F06D1B9-819E-42B9-ADF2-9CDFFFF6B715Q28391567-4DB1BE9D-9706-42DF-B2C2-E238A0CAA23CQ33648677-208EFC14-B331-48C0-BA72-85F9C252BD2CQ33653334-70D92042-2FBA-4905-98A9-A668F037B3DAQ34005217-95A2BB85-9D97-4B9A-B796-AE8EE178A2A3Q34124225-058CB62F-3271-400B-9C48-3EA003CCE4FDQ34130795-F10C9116-6EB6-45A9-B101-E84B37E01B9EQ34194679-3A2407D2-1CC5-465D-81E7-098743F2648EQ34445366-B6233E5F-1878-4FDD-8E17-0D038E50D7AAQ34886221-F8B6E12A-79BF-4DC8-8028-2220C800A23CQ35071155-0B7FAA3E-013D-44B7-9E94-85F30A3C911BQ35113092-F0AE8439-DCB6-4844-B1BF-6A01DFAB0EAFQ35689196-FE98F379-E597-4FB2-B02F-FDB0E0565D44Q36028197-8E6DD70D-3518-4876-84E4-8A8A00EE09CFQ36062124-296648FB-168E-4BDF-AA7D-2379F4F78DB8Q36300181-703C2B09-DEFF-4F7B-B3AA-7C83DE0D6ACCQ36316798-506FA5BB-7C46-43BE-BB71-00781C9C89E9Q36421541-ECB7FFED-E16C-4453-9037-2D891D3DC7A7Q36685400-2B401ED4-1089-40E9-AD15-09F6F5AEF3C6Q36845154-1429DFB0-B92D-42CB-9C3C-244960DA1B4FQ37159712-D36D8F14-92E2-4035-9C4E-19A66FC94C68Q37215938-EC10758E-2F5C-4F33-A3B4-9104683A4D86Q37333434-D65DEC33-4CD1-4BAC-BD4D-3A8E54AAA088Q37341897-E66FE203-5517-4884-B601-A2AA89AEBBA4Q37712799-A9BA43A8-F1A5-4ADA-A7AF-9B292A9BB95EQ37834874-C6E69D15-FF58-4AA4-9602-73104D8B18CCQ37849708-FBC37382-07CB-4646-952E-32A6139C4468Q37852183-FF7EEF59-8AE6-4717-9F7B-04FB476BFE91Q37859981-7D8EAD31-D72E-45FC-9DC6-AC111E5BF044Q37869350-EB223852-E827-46FA-B7F7-FA34DFF6C237
P2860
Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@ast
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@en
Priming with Chlamydia trachomatis major outer membrane protein
@nl
type
label
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@ast
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@en
Priming with Chlamydia trachomatis major outer membrane protein
@nl
prefLabel
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@ast
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@en
Priming with Chlamydia trachomatis major outer membrane protein
@nl
P2093
P2860
P1476
Priming with Chlamydia trachom ...... Th1 cellular immune responses.
@en
P2093
P2860
P304
P356
10.1128/IAI.68.6.3074-3078.2000
P407
P577
2000-06-01T00:00:00Z